T1	Participants 101 130	metastatic colorectal cancer:
T2	Participants 166 215	southern Italy cooperative oncology group trials.
T3	Participants 434 469	metastatic colorectal cancer (CRC).
T4	Participants 510 522	254 patients
T5	Participants 1782 1799	elderly patients.
